Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10787
Title: | The association between different molecular weights of hyaluronic acid and CHAD, HIF-1?, COL2A1 expression in chondrocyte cultures | Authors: | Şirin, D.Y. Kaplan, N. Yılmaz, I. Karaarslan, N. Özbek, H. Akyuva, Y. Kaya, Y.E. |
Keywords: | Chondroadherin Chondrocytes Collagen type II Hyaluronic acid Hypoxia-inducible factor 1? chondroadherin collagen type 2 hyaluronic acid hypoxia inducible factor 1alpha protein sinovial one unclassified drug viscoplus adult Article cell proliferation cell structure cell viability chondrocyte chondrocyte cultute clinical article controlled study female fluorescence microscopy gene expression gene expression assay human human tissue in vivo study knee osteoarthritis male microscopy middle aged molecular weight MTT assay primary culture real time polymerase chain reaction reverse transcription polymerase chain reaction staining |
Publisher: | Spandidos Publications | Abstract: | The aim of the present study was to investigate the effects of three different formulations of hyaluronic acid (HA): Low molecular weight (MW) Sinovial One®, medium MW Viscoplus® and high MW Durolane®, on chondrocyte proliferation and collagen type II (COL2A1), hypoxia-inducible factor 1? (HIF-1?) and chondroadherin (CHAD) expression in primary chondrocyte cultures. Standard primary chondrocyte cultures were established from osteochondral tissues surgically obtained from 6 patients with gonarthrosis. Cell morphology was evaluated using an inverted light microscope; cell proliferation was determined with a MTT assay and confirmed with acridine orange/propidium iodide staining. Levels of CHAD, COL2A1 and HIF-1? expression were assessed using specific TaqMan gene expression assays. The results demonstrated the positive effect of HA treatment on cell proliferation, which was independent from the MW. COL2A1 expression increased in the medium and high MW HA treated groups. It was observed that HIF-1? expression increased in the high MW treated group alone. CHAD expression increased only in the medium MW HA treated group. Evaluation of gene expression revealed that levels of expression increased as the duration of HA application increased, in the medium and high MW HA treated groups. In terms of increased viability and proliferation, a longer duration of HA application was more effective. Taken together, it may be concluded that the administration of medium and high MW HA may be a successful way of treating diseases affecting chondrocytes in a clinical setting. © 2018, Spandidos Publications. All rights reserved. | URI: | https://hdl.handle.net/11499/10787 https://doi.org/10.3892/etm.2018.5943 |
ISSN: | 1792-0981 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
The association.pdf | 1.56 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
18
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
17
checked on Nov 15, 2024
Page view(s)
42
checked on Aug 24, 2024
Download(s)
12
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.